P/Il L Partners Bvf
Affiliations
- Other at Palvella Therapeutics Inc. (PVLA), 2024-12-17
- Director, Other at Olema Pharmaceuticals Inc. (OLMA), 2024-12-05
- Other at 4D Molecular Therapeutics Inc. (FDMT), 2024-11-13
- Other at Third Harmonic Bio Inc. (THRD), 2024-10-31
- Large Shareholder at Eledon Pharmaceuticals Inc. (ELDN), 2024-10-31
- Large Shareholder, Director at Moonlake Immunotherapeutics (MLTX), 2024-10-08
- Director, Other at Kymera Therapeutics Inc. (KYMR), 2024-08-22
- Director, Other at Rain Oncology Inc. (RAIN), 2024-01-30
- Large Shareholder at Allakos Inc. (ALLK), 2024-01-26
- Other at Point Biopharma Global Inc. (PNT), 2023-12-20
- Large Shareholder at Repare Therapeutics Inc. (RPTX), 2023-11-17
- Large Shareholder at Engene Holdings Inc. (ENGN), 2023-11-13
- Large Shareholder, Director, Other at Cti Biopharma Corp (CTIC), 2023-06-28
- Large Shareholder, Director, Other at Xoma Corp (XOMA), 2023-05-19
- Large Shareholder at Structure Therapeutics Inc. (GPCR), 2023-05-13
- Large Shareholder at Cullinan Oncology Inc. (CGEM), 2023-01-19
- Large Shareholder at Essa Pharma Inc. (EPIX), 2022-07-21
- Large Shareholder at Verastem Inc. (VSTM), 2022-02-08
- Large Shareholder at Merus N.v. (MRUS), 2021-10-09
- Large Shareholder at Five Prime Therapeutics Inc. (FPRX), 2021-03-08
- Other at Infinity Pharmaceuticals Inc. (INFI), 2021-02-19
- Other at Cytomx Therapeutics Inc. (CTMX), 2021-02-19
- Other at Ideaya Biosciences Inc. (IDYA), 2021-02-04
- Other at Cytokinetics Inc (CYTK), 2020-12-11
- Large Shareholder at Glycomimetics Inc (GLYC), 2020-11-06
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2020-08-20
- Large Shareholder at Calithera Biosciences Inc. (CALA), 2020-05-26
- Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2019-06-12
- Large Shareholder at Immune Design Corp. (IMDZ), 2018-12-05
- Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2018-06-20
- Large Shareholder at Arqule Inc (ARQL), 2018-06-01
- Large Shareholder at Xenon Pharmaceuticals Inc. (XENE), 2018-03-29
- Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2017-11-27
- Other at Capstone Therapeutics Corp. (CAPS), 2017-07-18
- Large Shareholder at Nivalis Therapeutics Inc. (NVLS), 2017-06-22
- Large Shareholder at Cascadian Therapeutics Inc. (ONTY), 2016-06-27
- Other at Chemocentryx Inc. (CCXI), 2015-11-05
- Other at Catalyst Biosciences Inc. (TRGT), 2015-08-21
- Other at Array Biopharma Inc (ARRY), 2014-07-10
- Other at Ligand Pharmaceuticals Inc (LGND), 2014-03-26
- Other at Regado Biosciences Inc (RGDO), 2014-03-25
- Large Shareholder at Palatin Technologies Inc (PTN), 2014-03-03
- Large Shareholder at Rigel Pharmaceuticals Inc (RIGL), 2013-11-20
- Other at Neurocrine Biosciences Inc (NBIX), 2012-02-10
- Other at Kent International Holdings Inc (KENT), 2011-12-29
- Large Shareholder at Icagen Inc (ICGN), 2011-09-09
- Large Shareholder at Celera Corp (CRA), 2011-05-17
- Large Shareholder at Supergen Inc (SUPG), 2010-04-21
- Large Shareholder at Facet Biotech Corp (FACT), 2010-02-09
- Large Shareholder at Combinatorx Inc (CRXX), 2009-12-24
- Large Shareholder at Avigen Inc (AVGN), 2009-11-20
- Large Shareholder at Neurobiological Technologies Inc (NTII), 2009-10-23
- Large Shareholder at Adolor Corp (ADLR), 2009-09-24
- Large Shareholder at Dynavax Technologies Corp (DVAX), 2009-09-11
- Large Shareholder, Other at Repligen Corp (RGEN), 2009-07-08
- Large Shareholder, Other at Curis Inc (CRIS), 2009-04-29
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
ELDN | $0.00 | 75,431 | Large Shareholder | 220,460 | 2024-05-09 | Filing | |
ELDN | $0.00 | 821,121 | Large Shareholder | 2,633,679 | 2024-05-09 | Filing | |
ELDN | $0.00 | 1,031,385 | Large Shareholder | 3,361,803 | 2024-05-09 | Filing | |
RPTX | $5.38 | 16,143 | Large Shareholder | 548,938 | 2023-11-16 | Filing | |
RPTX | $5.38 | 125,909 | Large Shareholder | 4,308,573 | 2023-11-16 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
THRD | $14.30 | 64,617 | Other | 176,692 | 2024-10-29 | Filing | |
THRD | $14.30 | 396,963 | Other | 1,367,257 | 2024-10-29 | Filing | |
THRD | $14.30 | 538,420 | Other | 1,794,218 | 2024-10-29 | Filing | |
MLTX | $50.00 | 132,549 | Large Shareholder, Director | 1,287,768 | 2024-10-04 | Filing | |
MLTX | $50.00 | 836,862 | Large Shareholder, Director | 8,168,838 | 2024-10-04 | Filing |